Form S-3ASR
AS
FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON MAY 16,
2006.
|
REGISTRATION
NO. 333-________
|
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
______________________
FORM
S-3
REGISTRATION
STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
______________________
Interface,
Inc.
(Exact
Name of Issuer as Specified in its Charter)
Georgia
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
|
58-1451243
(I.R.S.
Employer
Identification
Number)
|
2859
Paces Ferry Road, Suite 2000
Atlanta,
Georgia 30339
(770)
427-6800
(Address,
including zip code, and telephone number,
including
area code, of registrant’s principal executive
offices)
|
Raymond
S. Willoch, Esquire
Senior
Vice President-Administration,
General
Counsel and Secretary
Interface,
Inc.
2859
Paces Ferry Road, Suite 2000, Atlanta, Georgia 30339
(770)
437-6800
(Name,
address, including zip code, and telephone number,
including
area code, of agent for service)
|
Copy
to:
W.
Randy Eaddy, Esquire
Kilpatrick
Stockton LLP
1100
Peachtree Street, Atlanta, Georgia 30309-4530
Telephone:
(404) 815-6500
|
Approximate
date of commencement of proposed sale to the public:
From
time to time after this Registration Statement becomes effective.
If
the
only securities being registered on this Form are being offered pursuant to
dividend or interest reinvestment plans, please check the following box. o
If
any of
the securities being registered on this Form are to be offered on a delayed
or
continuous basis pursuant to Rule 415 under the Securities Act of 1933 (the
“Securities Act”), other than securities offered only in connection with
dividend or interest reinvestment plans, check the following box. x
If
this
Form is filed to register additional securities for an offering pursuant to
Rule
462(b) under the Securities Act, check the following box and list the Securities
Act registration statement number of the earlier effective registration
statement for the same offering. o____________
If
this
Form is a post-effective amendment filed pursuant to Rule 462(c) under the
Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same
offering. o_______________
If
this
Form is a registration statement pursuant to General Instruction I.D. or a
post-effective amendment thereto that shall become effective upon filing with
the Commission pursuant to Rule 462(e) under the Securities Act, check the
following box. x
If
this
Form is a post-effective amendment to a registration statement filed pursuant
to
General Instruction I.D. filed to register securities or additional classes
of
securities pursuant to Rule 413(b) under the Securities Act, check the following
box. o
CALCULATION
OF REGISTRATION FEE
Title
of Each Class of Securities to be Registered
|
Amount
to be Registered(1)
|
Proposed
Maximum Offering Price Per Unit(1)
|
Proposed
Maximum Aggregate Offering Price(1)
|
Registration
Fee(1)
|
Common
Stock(2)
|
|
|
|
|
Preferred
Stock
|
|
|
|
|
Depositary
Shares(3)
|
|
|
|
|
Debt
Securities
|
|
|
|
|
Warrants
|
|
|
|
|
(1)
|
An
indeterminate aggregate initial offering price or amount of the securities
of each identified class is being registered as may from time to
time be
offered at indeterminate prices. Separate consideration may or may
not be
received for securities that are issuable upon exercise, conversion
or
exchange of other securities or that are issued in units or represented
by
depositary shares. In accordance with Rules 456(b) and 457(r), the
registrant is deferring payment of all of the registration
fee.
|
(2)
|
Each
share of common stock includes one preferred stock purchase right
as
described under “Description of Capital Stock”. No separate consideration
will be received for the preferred stock purchase
rights.
|
(3)
|
Each
depositary share will be issued under a deposit agreement, will represent
an interest in a fractional share or multiple shares of preferred
stock
and will be evidenced by a depositary
receipt.
|
PROSPECTUS
Common
Stock
Preferred
Stock
Depositary
Shares
Debt
Securities
Warrants
We
may
from time to time offer to sell common stock, preferred stock, depositary
shares, debt securities or warrants. Each time we sell securities pursuant
to
this prospectus, we will provide a new prospectus or a supplement to this
prospectus that contains specific information about the offering and the
specific terms of the securities offered. You should read this prospectus and
any other applicable prospectus or prospectus supplement carefully before you
invest in our securities.
This
prospectus may not be used to sell securities unless it is accompanied by a
prospectus supplement that contains a description of those
securities.
Our
Class
A common stock is quoted on the Nasdaq National Market under the symbol IFSIA.
Investing
in our securities involves risks. See “Risk Factors” beginning on page
2.
Neither
the Securities and Exchange Commission nor any state securities commission
has
approved or disapproved of these securities or determined that this prospectus
is truthful or complete. Any representation to the contrary is a criminal
offense.
The
date
of this prospectus is May 16, 2006.
This
prospectus is part of a registration statement that we filed with the Securities
and Exchange Commission, using a “shelf” registration process. Under this
shelf process, we
may
from time to time offer to sell common stock, preferred stock, depositary
shares, debt securities, warrants, or any
combination thereof, in one or more offerings.
Each
time we sell securities pursuant to this prospectus, we will provide a
prospectus or a supplement to this prospectus that contains specific information
about the offering and the specific terms of the securities offered. You should
read this prospectus and any other applicable prospectus or prospectus
supplement carefully before you invest in our securities.
Unless
the context indicates otherwise, all references in this prospectus to we, our,
us, or the company refer to Interface, Inc. and its subsidiaries on a
consolidated basis.
|
Page
|
|
i
|
|
ii
|
|
ii
|
|
ii
|
|
iii
|
|
1
|
|
2
|
|
4
|
|
4
|
|
4
|
|
9
|
|
11
|
|
13
|
|
16
|
|
17
|
|
17
|
You
should rely only on the information contained or incorporated by reference
in
this prospectus or the documents to which we have referred you or information
that is contained in any free writing prospectus we may authorize to be
delivered to you. We have not authorized anyone to provide you with information
that is different from such information. If anyone provides you with different
information, you should not rely on it. We have not authorized anyone to provide
you with different information. The information contained in this prospectus
is
accurate only as of the date of each document regardless of the time of delivery
of this prospectus or any sale of these securities. In case there are any
differences or inconsistencies between this prospectus and the information
incorporated by reference, you should rely on the information in the document
with the latest date.
A
WARNING ABOUT FORWARD-LOOKING
STATEMENTS
This
prospectus, any prospectus supplement (and other documents to which each refers)
contains statements about future events and expectations which are characterized
as forward-looking statements. Words such as “may”, “could”, “would”, “should”,
“believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”,
“targets”, “objectives”, “seek”, “strive”, negatives of these words and similar
expressions are intended to identify forward-looking statements. Forward-looking
statements are based on management’s beliefs, assumptions and expectations of
our future economic performance, taking into account the information currently
available to our management. They are expressions based on historical fact,
but
do not guarantee future performance. Forward-looking statements involve risks,
uncertainties and assumptions and certain other factors that may cause our
actual results, performance or financial condition to differ materially from
the
expectations of future results, performance or financial condition we express
or
imply in any forward-looking statements. Factors that could contribute to these
differences include those discussed in “Risk Factors” and in other sections of
this prospectus. We qualify any forward-looking statements entirely by these
cautionary factors.
We
believe these forward-looking statements are reasonable, but we caution that
you
should not place undue reliance on these forward-looking statements, because
our
future results and shareholder values may differ materially from those expressed
or implied by these forward-looking statements. We do not intend to update
any
forward-looking statement, whether written or oral, relating to the matters
discussed in this prospectus.
WHERE
YOU
CAN FIND MORE INFORMATION
We
are
subject to the information requirements of the Securities Exchange Act of 1934
(the “Exchange Act”), which means that we are required to file reports, proxy
statements, and other information, all of which are available at the Public
Reference Section of the Securities and Exchange Commission at Room 1580, 100
F.
Street, NE, Washington, D.C. 20549. You may also obtain copies of the reports,
proxy statements, and other information from the Public Reference Section of
the
SEC, at prescribed rates, by calling 1-800-SEC-0330. The SEC maintains an
Internet website at http://www.sec.gov where you can access reports, proxy,
information and registration statements, and other information regarding
registrants that file electronically with the SEC through the EDGAR
system.
We
have
filed a registration statement on Form S-3 to register the securities to be
issued pursuant to this prospectus. As allowed by SEC rules, this prospectus
does not contain all of the information you can find in the registration
statement or the exhibits to the registration statement because some parts
of
the registration statement are omitted in accordance with the rules and
regulations of the SEC. You may obtain a copy of the registration statement
from
the SEC at the address listed above or from the SEC’s website.
We
also
maintain an Internet website at http://www.interfaceinc.com, which provides
additional information about our company through which you can also access
our
SEC filings. The information set forth on our website is not part of this
prospectus.
In
this
prospectus, we use several of our trademarks including: Bentley®,
Bentley Prince Street™,
Chatham®,
Guilford
of Maine®,
Heuga®,
Interface®,
InterfaceFLOR™,
Intersept®,
Prince
Street®,
Prince
Street House and Home™
and
Terratex®.
All
brand names or other trademarks appearing in this prospectus are the property
of
their respective holders.
This
prospectus incorporates important business and financial information about
us
which is not included in or delivered with this prospectus. The information
in
the documents incorporated by reference is considered to be part of this
prospectus. Statements contained in documents that we file with the SEC and
that
are incorporated by reference in this prospectus automatically update and
supersede information contained in this prospectus, including information in
previously filed documents or reports that have been incorporated by reference
in this prospectus, to the extent the new information differs from or is
inconsistent with the old information. The following documents filed by us
under
the Exchange Act are incorporated by reference into this prospectus as of their
respective dates of filing:
|
· |
our
Form 10-K for the fiscal year ended January 1,
2006;
|
|
· |
our
Proxy Statement for the 2006 Annual
Meeting;
|
|
· |
our
Form 10-Q for the quarter ended April 2,
2006;
|
|
· |
our
Form 8-Ks filed with the SEC on April 11, 2006 and April 26,
2006;
|
|
·
|
all
other reports filed by us pursuant to Sections 13(a) or 15(d) of
the
Exchange Act since January 1, 2006;
and
|
|
·
|
all
documents filed after the date of this prospectus pursuant to Sections
13(a), 13(c), 14 or 15(d) of the Exchange
Act.
|
Documents
incorporated by reference are available from us without charge, excluding all
exhibits, unless an exhibit has been specifically incorporated by reference
in
this prospectus. You may obtain documents incorporated by reference in this
prospectus by requesting them in writing, by telephone, by facsimile or by
e-mail from Patrick C. Lynch, Chief Financial Officer, Interface, Inc., at
2859
Paces Ferry Road, Atlanta, Georgia 30339; telephone number (770) 437-6800;
facsimile number (770) 437-6887; e-mail address
patrick.lynch@us.interfaceinc.com.
We
are
the worldwide leader in design, production and sales of modular carpet, and
we
are a leading manufacturer and marketer of other products for the interiors
market, with a strong presence in the broadloom carpet, panel fabrics and
upholstery fabrics market segments. We market products in over 100 countries
around the world under such brand names as Interface®,
Heuga®, Bentley Prince Street™ and
InterfaceFLOR™
in
modular carpet; Bentley
Prince Street and
Prince
Street House and Home™ in
broadloom carpet; Guilford
of Maine®, Chatham® and
Terratex™ in
interior fabrics and upholstery products; and Intersept®
in
antimicrobial chemicals. Our sales force is one of the largest in the global
commercial floorcovering industry. Our principal geographic markets are the
Americas, Europe and Asia-Pacific, where our sales were approximately 62%,
31%
and 7%, respectively, of total net sales for fiscal year 2005.
Our
market share, which we believe is approximately 35% of the specified carpet
tile
segment (which is the segment where architects and designers are heavily
involved in “specifying”, or selecting, the carpet), is more than double that of
our nearest competitor. In the broadloom market segment, our Bentley
Prince Street brand
is
the leader in the high-end, designer-oriented sector, where custom design and
high quality are the principal specifying and purchasing factors. Our Fabrics
Group includes the leading U.S. manufacturer of panel fabrics for use in open
plan office furniture systems, with a market share we believe to be
approximately 50%, and the leading manufacturer of contract upholstery fabrics
sold to office furniture manufacturers in the United States, with a market
shares we believe to be approximately 30%.
Drawing
upon these strengths — especially our historical leadership in modular
carpet for the corporate office segment — we are increasing our presence and
market share in other non-corporate market segments, such as government,
healthcare, hospitality, education and retail space, and we have begun to
develop our business in the much larger residential market segment.
The U.S. residential market segment for carpet is approximately $11 billion,
and
the combined U.S. market for carpet in the other commercial and institutional
market segments is almost twice the size of the corporate office segment. The
appeal and utilization of modular carpet is expanding rapidly in each of these
markets, and we are using our considerable skills and experience with designing,
producing and marketing modular products to support and facilitate our
penetration into these new markets.
We
weathered successfully the unprecedented downturn, both in severity and
duration, in the commercial interiors industry from 2001 to 2003, and we emerged
better positioned for a resurgence as economic conditions began to improve
and
the interiors industry began to recover in the second half of 2004. Our modular
product dominance, strong business model, continued implementation of strategic
restructuring initiatives we had commenced in 2000, and sustained strategic
investments in innovative product concepts and designs during that period,
all
contributed to that success and the reduction in our exposure to economic and
business cycles that affect the corporate office segment more adversely than
other segment of the interiors industry. While maintaining our historical
dominance in modular products and fabrics for the corporate office segment,
we
also built upon that dominance and the strength of our high-end specified
broadloom carpet businesses to penetrate additional segments of the interiors
market.
_________________________________________________
Interface,
Inc., a Georgia corporation, began operations in 1973. Our principal offices
are
located at 2859 Paces Ferry Road, Suite 2000, Atlanta, Georgia 30339, where
our
telephone number is (770) 437-6800.
A
detailed discussion of our business is included in our Annual Report on Form
10-K for the fiscal year ended January 1, 2006 and our Quarterly Report on
Form
10-Q for the quarter ended April 2, 2006, both of which are incorporated herein
by reference.
You
should carefully consider the following factors, in addition to the other
information included in this prospectus, before making an investment in our
securities. Any or all of the risk factors could have a material adverse effect
on our business, financial condition, results of operation and prospects.
We
compete with a large number of manufacturers in the highly competitive
commercial floorcovering products market, and some of these competitors have
greater financial resources than we do.
The
commercial floorcovering industry is highly competitive. Globally, we compete
for sales of floorcovering products with other carpet manufacturers and
manufacturers of vinyl and other types of floorcovering. Although the industry
has experienced significant consolidation, a large number of manufacturers
remain in the industry. Some of the competitors, including a number of large
diversified domestic and foreign companies who manufacture modular carpet as
one
segment of their business, have greater financial resources than we
do.
Sales
of our principal products have been and may continue to be affected by adverse
economic cycles in the construction and renovation of commercial and
institutional buildings.
Sales
of
our principal products are related to the construction and renovation of
commercial and institutional buildings. This activity is cyclical and has been
affected by the strength of a country’s or region’s general economy, prevailing
interest rates and other factors that lead to cost control measures by
businesses and other users of commercial or institutional space. The effects
of
cyclicality upon the corporate office segment tend to be more pronounced than
the effects upon the institutional segment. Historically, we have generated
more
sales in the corporate office segment than in any other market. The effects
of
cyclicality upon the new construction segment of the market also tend to be
more
pronounced than the effects upon the renovation segment. The recent adverse
cycle has significantly lessened the overall demand for commercial interiors
products, which has adversely affected our business during the past several
years. These effects may continue and could be more pronounced if the global
economy does not improve or is further weakened.
Our
success depends significantly upon the efforts, abilities and continued service
of our senior management executives and our principal design consultant, and
our
loss of any of them could affect us adversely.
We
believe that our success depends to a significant extent upon the efforts and
abilities of our senior management executives. In addition, we rely
significantly on the leadership that David Oakey of David Oakey Designs provides
to our internal design staff. Specifically, Oakey Designs provides product
design/production engineering services to us under an exclusive consulting
contract that contains non-competition covenants. Our current agreement with
Oakey Designs extends to April 2011. The loss of any of these key persons could
have an adverse impact on our business.
Our
substantial international operations are subject to various political, economic
and other uncertainties that could adversely affect our business results,
including by restrictive taxation or other government regulation and by foreign
currency fluctuations.
We
have
substantial international operations. In fiscal 2005, approximately 43% of
our
net sales and a significant portion of our production were outside the United
States, primarily in Europe but also in Asia-Pacific. Our corporate strategy
includes the expansion and growth of our international business on a worldwide
basis. As a result, our operations are subject to various political, economic
and other uncertainties, including risks of restrictive taxation policies,
changing political conditions and governmental regulations. We also make a
substantial portion of our net sales in currencies other than U.S. dollars
(approximately 43% of 2005 net sales), which subjects us to the risks inherent
in currency translations. The scope and volume of our global operations make
it
impossible to eliminate completely all foreign currency translation risks as
an
influence on our financial results.
Our
Chairman, together with other insiders, currently has sufficient voting power
to
elect a majority of our Board of Directors.
Our
Chairman, Ray C. Anderson, beneficially owns approximately 49% of our
outstanding Class B common stock. The holders of the Class B common stock are
entitled, as a class, to elect a majority of our Board of Directors. Therefore,
Mr. Anderson, together with other insiders, has sufficient voting power to
elect
a majority of the Board of Directors. On all other matters submitted to the
shareholders for a vote, the holders of the Class B common stock generally
vote
together as a single class with the holders of the Class A common stock. Mr.
Anderson’s beneficial ownership of the outstanding Class A and Class B common
stock combined is approximately 7%.
Large
increases in the cost of petroleum-based raw materials, which we are unable
to
pass through to our customers, could adversely affect
us.
Petroleum-based
products comprise the predominant portion of the cost of raw materials that
we
use in manufacturing. While we attempt to match cost increases with
corresponding price increases, continued large increases in the cost of
petroleum-based raw materials could adversely affect our financial results
if we
are unable to pass through such price increases to our customers.
Unanticipated
termination or interruption of any of our arrangements with our primary
third-party suppliers of synthetic fiber could have a material adverse effect
on
us.
Invista
Inc., a subsidiary of Koch Industries, Inc., currently supplies approximately
46% of our requirements for synthetic fiber (nylon), which is the principal
raw
material that we use in our carpet products. In addition, other of our
businesses have a high degree of dependence on their third party suppliers
of
synthetic fiber for certain products or markets. The unanticipated termination
or interruption of any of our supply arrangements with our current suppliers
could have a material adverse effect on us because of the cost and delay
associated with shifting more business to another supplier. We do not have
a
long-term supply agreement with Invista.
We
have a significant amount of indebtedness, which could have important negative
consequences to us.
Our
substantial indebtedness could have important negative consequences to us,
including:
|
• |
making
it more difficult for us to satisfy our obligations with respect
to such
indebtedness;
|
|
•
|
increasing
our vulnerability to adverse general economic and industry conditions
and
adverse changes in governmental regulations;
|
|
•
|
limiting
our ability to obtain additional financing to fund capital expenditures,
acquisitions or other growth initiatives, and other general corporate
requirements;
|
|
•
|
requiring
us to dedicate a substantial portion of our cash flow from operations
to
payments on our indebtedness, thereby reducing the availability of
our
cash flow to fund capital expenditures, acquisitions or other growth
initiatives, or other general corporate purposes;
|
|
•
|
limiting
our flexibility in planning for, or reacting to, changes in our business
and the industry in which we operate;
|
|
• |
placing
us at a competitive disadvantage compared to our less leveraged
competitors; and
|
|
• |
limiting
our ability to refinance our existing indebtedness as it
matures.
|
Our
Rights Agreement could discourage tender offers or other transactions for our
stock that could result in shareholders receiving a premium over the market
price for our stock.
Our
Board
of Directors adopted a Rights Agreement in 1998 pursuant to which holders of
our
common stock will be entitled to purchase from us a fraction of a share of
our
Series B Participating Cumulative Preferred Stock if a third party acquires
beneficial ownership of 15% or more of our common stock without our consent.
In
addition, the holders of our common stock will be entitled to purchase the
stock
of an Acquiring Person (as defined in the Rights Agreement) at a discount upon
the occurrence of triggering events. These provisions of the Rights Agreement
could have the effect of discouraging tender offers or other transactions that
could result in shareholders receiving a premium over the market price for
our
common stock.
We
intend
to use the net proceeds we receive from the sale of securities by us as set
forth in the applicable prospectus or prospectus supplement.
THE
SECURITIES
WE MAY OFFER
The
descriptions of the securities contained in this prospectus, together with
any
applicable prospectus or prospectus supplements, summarize all the material
terms and provisions of the various types of securities that we may offer.
We will describe in the applicable prospectus or prospectus supplement relating
to any securities the particular terms of the securities offered by that
prospectus or prospectus supplement. If we indicate in the applicable
prospectus or prospectus supplement, the terms of the securities may differ
from
the terms we have summarized below. We will also include in the prospectus
or prospectus supplement information, where applicable, about material United
States federal income tax considerations relating to the securities, and the
securities exchange, if any, on which the securities will be
listed.
We
may
sell from time to time, in one or more offerings:
|
·
|
warrants
to purchase any of the securities listed
above.
|
In
this
prospectus, we refer to the common stock, preferred stock, depositary shares,
debt securities and warrants collectively as “securities”.
We
are
authorized by our Amended and Restated Articles of Incorporation to issue
80,000,000 shares of Class A common stock, par value $.10 per share; 40,000,000
shares of Class B common stock, par value $.10 per share; and 5,000,000 shares
of preferred stock, par value $1.00 per share. On May
12,
2006,
we had
issued and outstanding 47,816,109 shares of Class A common
stock, 6,918,214 shares of Class B common stock and no shares of preferred
stock.
Class
A and Class B Common Stock
Voting.
The
Class A common stock and Class B common stock have one vote per share on all
matters submitted to our shareholders. The holders of the Class B common stock
have the right to elect the smallest number of directors that constitutes a
majority of our entire Board of Directors; the holders of the Class A common
stock elect the remaining directors. Each class may remove and replace any
directors elected by such class. The holders of shares of both classes vote
together as a class on all other matters submitted to the shareholders for
a
vote, except as otherwise required by law.
Conversion.
Shares
of our Class B common stock are convertible on a one-for-one basis into Class
A
common stock at any time at the option of the holder, and at other times upon
the transfer of Class B shares to an ineligible shareholder.
Stock
Dividends.
Holders
of our Class A common stock are entitled to receive the same percentage dividend
(payable in shares of Class A common stock) as the holders of Class B common
stock receive (payable in shares of Class B common stock).
Restrictions
on Transfer. Any
transfer of Class B common stock other than to a “Qualified Transferee” shall be
conclusively deemed to constitute an election by the record holder of such
shares to convert the shares of Class B common stock into an equal number of
shares of Class A common stock. “ Qualified Transferee” means any one or more of
(1) the holder’s spouse, issue, parents or siblings, or a trust for the benefit
of the holder or any of such persons, (2) in the event of the holder’s death or
legal disability, the holder’s executor, administrator or personal
representative, (3) any transferee receiving the shares as a gift, legacy or
inheritance, or as a distribution from a corporation or partnership in respect
of the transferee’s ownership interest, or (4) any other person approved by the
Board of Directors.
Issuance
of Class B Common Stock.
We may
only issue Class B common stock (1) in connection with an acquisition by
Interface or any of our subsidiaries of any other firm, corporation or business
enterprise, (2) pursuant to an employee benefit plan, (3) in exchange for Class
A common stock held by our officers, directors or employees, or (4) to effect
a
subdivision of such shares in the form of a stock split, stock dividend or
other
distribution in respect of such shares.
Liquidation.
Holders
of our Class A and Class B common stock share with each other on a ratable
basis
as a single class in our net assets available for distribution in respect of
Class A and Class B common stock in the event of liquidation.
Other
Terms.
The
holders of the Class A common stock and Class B common stock do not have
preemptive rights enabling them to subscribe for or receive shares of any class
of our stock or any other securities convertible into shares of any class of
our
stock. Except as otherwise summarized above, the holders of shares of both
our
classes of common stock, as such, have the same rights and are subject to the
same limitations. If the outstanding shares of Class B common stock fall below
10% of the aggregate outstanding shares of Class A and Class B common stock,
then, immediately upon the occurrence of such event, there shall be no
distinction between the voting rights or any other rights and privileges of
the
holders of Class A common stock and Class B common stock.
Preferred
Stock
General.
Under
our Amended and Restated Articles of Incorporation, our Board of Directors
is
authorized to create and issue up to 5,000,000 shares of preferred stock in
one
or more series and to determine the rights and preferences of each series,
to
the extent permitted by our Articles of Incorporation, and to fix the terms
of
such preferred stock without any vote or action by the shareholders. The
issuance of any series of preferred stock may have an adverse effect on the
rights of holders of common stock and could decrease the amount of earnings
and
assets available for distribution to holders of common stock. In addition,
any
issuance of preferred stock could have the effect of delaying, deferring or
preventing a change in control of the Company.
Series
A Cumulative Convertible Preferred Stock.
Our Amended and Restated Articles of Incorporation designate 250,000 shares
of preferred stock as Series A Cumulative Convertible Preferred Stock, $1.00
par
value per share. Shares of Series A Preferred Stock will entitle the
holder to a preferential cash dividend if and as declared by the Board of
Directors, at a rate of seven percent (7%) per annum on the sum of (1) the
face
value of each share of Series A Preferred Stock, plus (2)
the amount, if any, of previously accrued and due but unpaid dividends on
such share. Dividends on each issued and outstanding share of the Series A
Preferred Stock shall be cumulative and shall accrue, whether or not declared
and paid, from the date of original issuance. In the event
of liquidation, each share of Series A Preferred Stock will be entitled to
a preferential liquidation payment in cash equal to the face value per share
of outstanding Series A Preferred Stock plus the amount of accrued but
unpaid dividends accumulated thereon. Holders of Series A Preferred
Stock shall not be entitled to any further payment upon any such
liquidation.
Holders
of Series A Preferred Stock shall not have any right to vote or to give or
withhold consent on any matter on which a vote or consent of our shareholders
may be required, but shall be entitled to receive notice of any such meeting
at
which a vote or consent may be taken and all information provided by us to
holders of the Class A common stock. As long as any Series A
Preferred Stock remains outstanding, the affirmative vote or written consent
of
the holders of a majority of the Series A Preferred Stock will be required
for
any amendment to any provision of the Articles of Incorporation that would
adversely affect the powers, preferences, or special rights of all preferred
stock or all Series A Preferred Stock as a class.
Each
holder of a share of Series A Preferred Stock shall have the right to require
us
to redeem each share of Series A Preferred Stock by paying in cash for each
share the face value of each share of Series A Preferred Stock plus an amount
equal to the full dividends accrued but unpaid on each such share through the
redemption date, subject to any provisions in any contracts, credit agreements,
indentures, or other outstanding debt securities or instruments binding upon
us.
Series
B Participating Cumulative Preferred Stock. Our
Amended and Restated Articles of Incorporation designate 1,000,000 shares
of preferred stock as Series B Participating Cumulative Preferred Stock, $1.00
par value per share. The dividend and liquidation rights of the Series B
Preferred Stock are designed so that the value of one one-hundredth of a share
of Series B Preferred Stock issuable upon exercise of each right to acquire
Series B Preferred Stock under the Rights Agreement described below will
approximate the same economic value as one share of common stock, including
voting rights. Shares of Series B Preferred Stock will entitle the holder to
a
minimum preferential dividend of $1.00 per share, but will entitle the holder
to
an aggregate dividend payment of 100 times the dividend declared on each share
of common stock. In the event of liquidation, each share of Series B Preferred
Stock will be entitled to a minimum preferential liquidation payment of $1.00,
plus accrued and unpaid dividends and distributions thereon, but will be
entitled to an aggregate payment of 100 times the payment made per share of
common stock. In the event of any merger, consolidation or other transaction
in
which common stock is exchanged for or changed into other stock or securities,
cash or other property, each share of Series B Preferred Stock will be entitled
to receive 100 times the amount received per share of common stock. Series
B
Preferred Stock is not convertible into common stock.
Each
share of Series B Preferred Stock will be entitled to 100 votes on all matters
submitted to a vote of the shareholders of the Company, and shares of Series
B
Preferred Stock will generally vote together as one class with the common stock
and any other of our voting capital stock on all matters submitted to a vote
of
our shareholders. While our Class B common stock remains outstanding, holders
of
Series B Preferred Stock will vote as a single class with the Class A common
stockholders for election of directors.
Further,
whenever dividends on the Series B Preferred Stock are in arrears in an amount
equal to six quarterly payments, the Series B Preferred Stock, together
with any other shares of preferred stock then entitled to elect directors,
shall
have the right, as a single class, to elect one director until the default
has
been cured. The rights under the Rights Agreement expire on March 15, 2008
unless extended or unless the rights are earlier redeemed or exchanged by the
Company.
Rights
Agreement
Our
Board
of Directors has adopted a Rights Agreement pursuant to which holders of our
common stock will be entitled to purchase from us one one-hundredth of a share
of our Series B Participating Cumulative Preferred Stock if a third party
acquires beneficial ownership of 15% or more of our common stock or if other
specified events occur without our consent. In addition, the holders of our
common stock will be entitled to purchase the stock of an Acquiring Person
(as
defined in the Rights Agreement) at a discount upon the occurrence of triggering
events. The exercise price per right is $90, subject to adjustment. These
provisions of the Rights Agreement could have certain anti-takeover effects
because the rights provided to holders of our common stock under the Rights
Agreement will cause substantial dilution to a person or group that acquires
our
common stock or engages in other specified events without the rights under
the
agreement having been redeemed or in the event of an exchange of the rights
for
common stock as permitted under the agreement.
Certain
Provisions of our Bylaws
Article
III of our Amended and Restated Bylaws provides that a vote of two-thirds of
the
members of the Board of Directors is required to approve certain transactions
with, of or to any holder of 10% or more of our issued and outstanding shares.
Such approval is required in the event of a merger; consolidation; sale, lease,
exchange, transfer or disposition of all or any substantial part of our assets;
any share exchange; liquidation or dissolution; any repurchase, redemption
or
other distribution; or any other transaction that would have the affect of
increasing the beneficial ownership by one percent or more in any 12 month
period with, of or to any such holder, or if such a holder commences or
announces an intention to commence an exchange or tender offer of all or any
part of our outstanding voting shares or a proxy contest intended to cause
either the removal or replacement of any member of the Board.
Depositary
Shares
General.
We may,
at our option, elect to issue fractional shares of preferred stock, rather
than
full shares of preferred stock. If such option is exercised, we may elect to
have a depositary issue receipts for depositary shares, each receipt
representing a fraction (to be set forth in any applicable prospectus or
prospectus supplement relating to a particular series of preferred stock) of
a
share of a particular series of preferred stock as described below. The shares
of any series of preferred stock represented by depositary shares will be
deposited under a deposit agreement between us and a depositary. Subject to
the
terms of such a deposit agreement, each owner of a depositary share will be
entitled, in proportion to the applicable fraction of a share of preferred
stock
represented by such depositary share, to all the rights and preferences of
the
preferred stock represented thereby (including dividend, voting, redemption
and
liquidation rights).
Any
depositary shares will be evidenced by depositary receipts issued pursuant
to
such a deposit agreement. Depositary receipts will be distributed to those
persons purchasing the fractional shares of preferred stock in accordance with
the terms of an offering of the preferred stock. In connection with the issuance
of any series of preferred stock represented by depositary shares, the forms
of
deposit agreement and depositary receipt will be filed as exhibits to this
registration statement of which this prospectus is a part.
Pending
the preparation of definitive engraved depositary receipts, a depositary may,
upon our written order, issue temporary depositary receipts substantially
identical to (and entitling the holders thereof to all the rights pertaining
to)
the definitive depositary receipts but not in definitive form. Definitive
depositary receipts will be prepared thereafter without unreasonable delay,
and
temporary depositary receipts will be exchangeable for definitive depositary
receipts at our expense.
Upon
surrender of depositary receipts at the office of the depositary and upon
payment of the charges provided in the deposit agreement and subject to the
terms thereof, a holder of depositary receipts is entitled to have the
depositary deliver to such holder the whole shares of preferred stock relating
to the surrendered depositary receipts. Holders of depositary shares will be
entitled to receive whole shares of the related series of preferred stock on
the
basis set forth in any applicable prospectus or prospectus supplement for such
series of preferred stock, but holders of such whole shares will not thereafter
be entitled to receive depositary shares therefor. If the depositary receipts
delivered by the holder evidence a number of depositary shares in excess of
the
number of depositary shares representing the number of whole shares of the
related series of preferred stock to be withdrawn, the depositary will deliver
to such holder at the same time a new depositary receipt evidencing such excess
number of depositary shares.
Dividends
and Other Distributions. The
depositary will distribute all cash dividends or other cash distributions
received in respect of the preferred stock to the record holders of depositary
shares relating to such preferred stock in proportion to the numbers of such
depositary shares owned by such holders.
In
the
event of a distribution other than in cash, the depositary will distribute
property received by it to the record holders of depositary shares entitled
thereto, unless the depositary determines that it is not feasible to make such
distribution, in which case the depositary may, with our approval, sell such
property and distribute the net proceeds from such sale to such
holders.
Redemption
of Depositary Shares.
If a
series of preferred stock represented by depositary shares is subject to
redemption, the depositary shares will be redeemed from the proceeds received
by
the depositary resulting from the redemption, in whole or in part, of such
series of preferred stock held by the depositary. The redemption price per
depositary share will be equal to the applicable fraction of the redemption
price per share payable with respect to such series of the preferred stock.
Whenever we redeem shares of preferred stock held by the depositary, the
depositary will redeem as of the same redemption date the number of depositary
shares representing shares of preferred stock so redeemed. If less than all
the
depositary shares are to be redeemed, the depositary shares to be redeemed
will
be selected by lot or ratably as may be determined by the
depositary.
Voting
the Preferred Shares.
Upon
receipt of notice of any meeting at which the holders of the preferred stock
are
entitled to vote, the depositary will mail the information contained in such
notice of meeting to the record holders of the depositary shares relating to
such preferred stock. Each record holder of such depositary shares on the record
date (which will be the same date as the record date for the preferred stock)
will be entitled to instruct the depositary as to the exercise of the voting
rights pertaining to the amount of the preferred stock represented by such
holder’s depositary shares. The depositary will endeavor, insofar as
practicable, to vote the amount of the preferred stock represented by such
depositary shares in accordance with such instructions, and we will agree to
take all action which may be deemed necessary by the depositary in order to
enable the depositary to do so. The depositary will abstain from voting shares
of the preferred stock to the extent it does not receive specific instructions
from the holders of depositary shares representing such preferred
stock.
Amendment
and Termination of the Deposit Agreement.
The form
of depositary receipt evidencing the depositary shares and any provision of
any
deposit agreement may at any time be amended by agreement between us and the
depositary. However, any amendment which materially and adversely alters the
rights of the holders of depositary shares will not be effective unless such
amendment has been approved by the holders of at least a majority of the
depositary shares then outstanding. The deposit agreement may be terminated
by
us or the depositary only if (1) all outstanding depositary shares have been
redeemed or (2) there has been a final distribution in respect to the preferred
stock in connection with our liquidation, dissolution or winding up and such
distribution has been distributed to the holders of depositary
receipts.
Charges
of Depositary.
We
will
pay all transfer and other taxes and governmental charges arising solely from
the existence of the depositary arrangements. We will pay charges of the
depositary in connection with the initial deposit of the preferred stock and
any
redemption of the preferred stock. Holders of depositary receipts will pay
other
transfer and other taxes and governmental charges and such other charges as
are
expressly provided in the deposit agreement to be for their
accounts.
Miscellaneous.
The
depositary will forward to the record holders of the depositary shares relating
to such preferred stock all reports and communications from us which are
delivered to the depositary.
Neither
the depositary nor we will be liable if it is prevented or delayed by law or
any
circumstance beyond its control in performing its obligations under any deposit
agreement. The obligations of us and the depositary under the deposit agreement
will be limited to performance in good faith of their duties thereunder, and
they will not be obligated to prosecute or defend any legal proceeding in
respect of any depositary shares or preferred stock unless satisfactory
indemnity is furnished. They may rely upon written advice of counsel or
accountants, or information provided by persons presenting preferred stock
for
deposit, holders of depositary receipts or other persons believed to be
competent and on documents believed to be genuine.
Resignation
and Removal of Depositary.
The
depositary may resign at any time by delivering to us notice of its election
to
do so, and we may at any time remove the depositary, any such resignation or
removal to take effect upon the appointment of a successor depositary and its
acceptance of such appointment. Such successor depositary must be appointed
within 60 days after delivery of the notice of resignation or removal and must
be a bank or trust company having its principal office in the United States
and
having a combined capital and surplus of at least $50,000,000.
Transfer
Agent
The
transfer agent for our common stock is Computershare Trust Company,
N.A.
The
following description, together with the additional information we include
in
any applicable prospectus or prospectus supplement, summarizes the material
terms and provisions of the debt securities that we may offer under this
prospectus. While the terms we have summarized below will apply generally to
any
future debt securities we may offer, we will describe the particular terms
of
any debt securities that we may offer in more detail in the applicable
prospectus or prospectus supplement. If we so indicate in a prospectus or
prospectus supplement, the terms of any debt securities we offer under such
prospectus or prospectus supplement may differ from the terms we describe
below.
General
We
may
enter into indenture agreements with respect to any debt securities we may
offer. We would enter into separate indentures, with different trustees, for
(1)
any and all senior debt securities and (2) any and all subordinated debt
securities. We use the term “indentures” to refer to the form of senior
indenture and the subordinated indenture and any additional such indenture
we
may enter into in the future, and we use the term “trustees” to refer to the
several trustees under such indentures. The material terms of any future
indenture governing a series of debt securities will be described in the
applicable prospectus or prospectus supplement. The indentures will be
qualified under the Trust Indenture Act.
Additional
Information
We
will
describe in any applicable prospectus or prospectus supplement the following
terms relating to a series of debt securities:
|
·
|
any
limit on the amount that may be
issued;
|
|
·
|
whether
or not we will issue the series of notes in global form, the terms
and who
the depository will be;
|
|
·
|
the
annual interest rate, which may be fixed or variable, or the method
for
determining the rate and the date interest will begin to accrue,
the dates
interest will be payable and the regular record dates for interest
payment
dates or the method for determining such
dates;
|
|
·
|
whether
or not the notes will be secured or unsecured, and the terms of any
secured debt;
|
|
·
|
the
terms of the subordination of any series of subordinated
debt;
|
|
·
|
the
place where payments will be
payable;
|
|
·
|
our
right, if any, to defer payment of interest and the maximum length
of any
such deferral period;
|
|
·
|
the
date, if any, after which, and the price at which, we may, at our
option,
redeem the series of notes pursuant to any optional redemption
provisions;
|
|
·
|
the
date, if any, on which, and the price at which we are obligated,
pursuant
to any mandatory sinking fund provisions or otherwise, to redeem,
or at
the holder’s option to purchase, the series of
notes;
|
|
·
|
whether
the indenture will restrict our ability to pay dividends, or will
require
us to maintain any asset ratios or
reserves;
|
|
·
|
whether
we will be restricted from incurring any additional
indebtedness;
|
|
·
|
a
discussion on any material or special United States federal income
tax
considerations applicable to the
notes;
|
|
·
|
the
denominations in which we will issue the series of notes, if other
than
denominations of $1,000 and any integral multiple thereof;
and
|
|
·
|
any
other specific terms, preferences, rights or limitations of, or
restrictions on, the debt
securities.
|
Conversion
or Exchange of Debt Securities
Such
prospectus or prospectus supplement will also describe, if applicable, the
terms
on which the debt securities may be converted or exchanged into our common
stock, preferred stock or other securities or property. These terms will include
whether the conversion or exchange is mandatory, is at our option or is at
the
option of the holder. The prospectus supplement will describe how the number
of
common stock, preferred stock or other securities or property to be received
would be calculated.
The
following description, together with the additional information we may include
in any applicable prospectus or prospectus supplement, summarizes the material
terms and provisions of the warrants that we may offer under this prospectus
and
the related warrant agreements and warrant certificates. While the terms
summarized below will apply generally to any warrants that we may offer, we
will
describe the particular terms of any series of warrants in more detail in the
applicable prospectus or prospectus supplement. If we indicate in the prospectus
or prospectus supplement, the terms of any warrants offered under that
prospectus or prospectus supplement may differ from the terms described below.
Specific warrant agreements will contain additional important terms and
provisions and will be incorporated by reference as an exhibit to the
registration statement that includes this prospectus.
General
We
may
issue warrants for the purchase of common stock, preferred stock or debt
securities in one or more series. We may issue warrants independently or
together with common stock, preferred stock and debt securities, and the
warrants may be attached to or separate from these securities.
We
will
evidence each series of warrants by warrant certificates that we will issue
under a separate agreement. We may enter into the warrant agreement with a
warrant agent. We will indicate the name and address and other information
regarding the warrant agent in the applicable prospectus or prospectus
supplement relating to a particular series of warrants.
Before
exercising their warrants, holders of warrants will not have any of the rights
of holders of the securities purchasable upon such exercise,
including:
|
·
|
in
the case of warrants to purchase debt securities, the right to receive
payments of principal of, or premium, if any, or interest on, the
debt
securities purchasable upon exercise or to enforce covenants in the
applicable indenture; or
|
|
·
|
in
the case of warrants to purchase common stock or preferred stock,
the
right to receive dividends, if any, or, payments upon our liquidation,
dissolution or winding up or to exercise voting rights, if
any.
|
Additional
Information
We
will
describe in an applicable prospectus or prospectus supplement the terms of
the
series of warrants, including:
|
·
|
the
offering price and aggregate number of warrants
offered;
|
|
·
|
the
currency for which the warrants may be
purchased;
|
|
·
|
if
applicable, the designation and terms of the securities with which
the
warrants are issued and the number of warrants issued with each such
security or each principal amount of such
security;
|
|
·
|
if
applicable, the date on and after which the warrants and the related
securities will be separately
transferable;
|
|
·
|
in
the case of warrants to purchase debt securities, the principal amount
of
debt securities purchasable upon exercise of one warrant and the
price at,
and currency in which, this principal amount of debt securities may
be
purchased upon such exercise;
|
|
·
|
in
the case of warrants to purchase common stock or preferred stock,
the
number of shares of common stock or preferred stock, as the case
may be,
purchasable upon the exercise of one warrant and the price at which
these
shares may be purchased upon such
exercise;
|
|
·
|
the
effect of any merger, consolidation, sale or other disposition of
our
business on the warrant agreement and the
warrants;
|
|
·
|
the
terms of any rights to redeem or call the
warrants;
|
|
·
|
any
provisions for changes to or adjustments in the exercise price or
number
of securities issuable upon exercise of the
warrants;
|
|
·
|
the
dates on which the right to exercise the warrants will commence and
expire;
|
|
·
|
the
manner in which the warrant agreement and warrants may be
modified;
|
|
·
|
a
discussion on any material or special United States federal income
tax
consequences of holding or exercising the
warrants;
|
|
·
|
the
terms of the securities issuable upon exercise of the warrants;
and
|
|
·
|
any
other specific terms, preferences, rights or limitations of or
restrictions on the warrants.
|
Exercise
of Warrants
Each
warrant will entitle the holder to purchase the securities that we specify
in
the applicable prospectus or prospectus supplement at the exercise price that
we
describe in the applicable prospectus or prospectus supplement. Unless we
otherwise specify in the applicable prospectus or prospectus supplement, holders
of the warrants may exercise the warrants at any time up to 5 p.m., Eastern
time, on the expiration date that we set forth in the applicable prospectus
or
prospectus supplement. After the close of business on the expiration date,
unexercised warrants will become void.
Holders
of the warrants may exercise the warrants by delivering the warrant certificate
representing the warrants to be exercised together with specified information,
and paying the required amount to the warrant agent in immediately available
funds, as provided in the applicable prospectus or prospectus supplement. We
will set forth on the reverse side of the warrant certificate and in the
applicable prospectus or prospectus supplement the information that the holder
of the warrant will be required to deliver to the warrant agent.
Upon
receipt of the required payment and the warrant certificate properly completed
and duly executed at the corporate trust office of the warrant agent or any
other office indicated in the applicable prospectus or prospectus supplement,
we
will issue and deliver the securities purchasable upon such exercise. If fewer
than all of the warrants represented by the warrant certificate are exercised,
then we will issue a new warrant certificate for the remaining amount of
warrants. If we so indicate in the applicable prospectus or prospectus
supplement, holders of the warrants may surrender securities as all or part
of
the exercise price for warrants.
Enforceability
of Rights by Holders of Warrants
Each
warrant agent will act solely as our agent under the applicable warrant
agreement and will not assume any obligation or relationship of agency or trust
with any holder of any warrant. A single bank or trust company may act as
warrant agent for more than one issue of warrants. A warrant agent will
have no duty or responsibility in case of any default by us under the applicable
warrant agreement or warrant, including any duty or responsibility to initiate
any proceedings at law or otherwise, or to make any demand upon us. Any
holder of a warrant may, without the consent of the related warrant agent or
the
holder of any other warrant, enforce by appropriate legal action its right to
exercise, and receive the securities purchasable upon exercise of, its
warrants.
LEGAL
OWNERSHIP
OF SECURITIES
We
can
issue securities in registered form or in the form of one or more global
securities. We describe global securities in greater detail below.
We refer to those persons who have securities registered in their own names
on
the books that we or any applicable trustee maintain for this purpose as the
“holders” of those securities. These persons are the legal holders of the
securities. We refer to those persons who, indirectly through others, own
beneficial interests in securities that are not registered in their own names,
as “indirect holders” of those securities. As we discuss below, indirect
holders are not legal holders, and investors in securities issued in book-entry
form or in street name will be indirect holders.
Book-Entry
Holders
We
may
issue securities in book-entry form only, as we will specify in the applicable
prospectus supplement. This means securities may be represented by one or
more global securities registered in the name of a financial institution that
holds them as depositary on behalf of other financial institutions that
participate in the depositary’s book-entry system. These participating
institutions, which are referred to as participants, in turn, hold beneficial
interests in the securities on behalf of themselves or their
customers.
Only
the
person in whose name a security is registered is recognized as the holder of
that security. Securities issued in global form will be registered in the
name of the depositary or its participants. Consequently, for securities
issued in global form, we will recognize only the depositary as the holder
of
the securities, and we will make all payments on the securities to the
depositary. The depositary passes along the payments it receives to its
participants, which in turn pass the payments along to their customers who
are
the beneficial owners. The depositary and its participants do so under
agreements they have made with one another or with their customers; they are
not
obligated to do so under the terms of the securities.
As
a
result, investors in a book-entry security will not own securities
directly. Instead, they will own beneficial interests in a global
security, through a bank, broker or other financial institution that
participates in the depositary’s book-entry system or holds an interest through
a participant. As long as the securities are issued in global form,
investors will be indirect holders, and not holders, of the
securities.
Street
Name Holders
We
may
terminate a global security or issue securities in non-global form. In
these cases, investors may choose to hold their securities in their own names
or
in “street name”. Securities held by an investor in street name would be
registered in the name of a bank, broker or other financial institution that
the
investor chooses, and the investor would hold only a beneficial interest in
those securities through an account he or she maintains at that
institution.
For
securities held in street name, we will recognize only the intermediary banks,
brokers and other financial institutions in whose names the securities are
registered as the holders of those securities, and we will make all payments
on
those securities to them. These institutions pass along the payments they
receive to their customers who are the beneficial owners, but only because
they
agree to do so in their customer agreements or because they are legally required
to do so. Investors who hold securities in street name will be indirect
holders, not holders, of those securities.
Legal
Holders
Our
obligations, as well as the obligations of any applicable trustee and of any
third parties employed by us or a trustee, run only to the legal holders of
the
securities. We do not have obligations to investors who hold beneficial
interests in global securities, in street name or by any other indirect
means. This will be the case whether an investor chooses to be an indirect
holder of a security or if we issue the securities only in global
form.
For
example, once we make a payment or give a notice to the holder, we have no
further responsibility for the payment or notice even if that holder is
required, under agreements with depositary participants or customers or by
law,
to pass it along to the indirect holders but does not do so. Similarly, we
may want to obtain the approval of the holders to amend an indenture, to relieve
us of the consequences of a default or of our obligation to comply with a
particular provision of the indenture or for other purposes. In such an
event, we would seek approval only from the holders, and not the indirect
holders, of the securities. Whether and how the holders contact the
indirect holders is up to the holders.
Special
Considerations for Indirect Holders
If
you
hold securities through a bank, broker or other financial institution, either
in
book-entry form or in street name, you should check with your own institution
to
find out:
|
• |
how
it handles securities payments and
notices;
|
|
• |
whether
it imposes fees or charges;
|
|
• |
how
it would handle a request for the holders’ consent, if ever
required;
|
|
• |
whether
and how you can instruct it to send you securities registered in
your own
name so you can be a holder, if that is permitted in the
future;
|
|
• |
how
it would exercise rights under the securities if there were a default
or
other event triggering the need for holders to act to protect their
interests; and
|
|
• |
if
the securities are in book-entry form, how the depositary’s rules and
procedures will affect these
matters.
|
Global
Securities
A
global
security is a security held by a depositary that represents one or any other
number of individual securities. Generally, all securities represented by
the same global securities will have the same terms.
Each
security issued in book-entry form will be represented by a global security
that
we deposit with and register in the name of a financial institution or its
nominee that we select. The financial institution that we select for this
purpose is called the depositary. Unless we specify otherwise in the
applicable prospectus supplement, The Depository Trust Company, New York, New
York, known as DTC, will be the depositary for all securities issued in
book-entry form.
A
global
security may not be transferred to or registered in the name of anyone other
than the depositary, its nominee or a successor depositary, unless special
termination situations arise. We describe those situations below under
“Special Situations When a Global Security will be Terminated”. As a
result of these arrangements, the depositary, or its nominee, will be the sole
registered owner and holder of all securities represented by a global security,
and investors will be permitted to own only beneficial interests in a global
security. Beneficial interests must be held by means of an account with a
broker, bank or other financial institution that in turn has an account with
the
depositary or with another institution that does. Thus, an investor whose
security is represented by a global security will not be a holder of the
security, but only an indirect holder of a beneficial interest in the global
security.
If
the
prospectus or prospectus supplement for a particular security indicates that
the
security will be issued in global form only, then the security will be
represented by a global security at all times unless and until the global
security is terminated. If termination occurs, we may issue the securities
through another book-entry clearing system or decide that the securities may
no
longer be held through any book-entry clearing system.
Special
Considerations for Global Securities
As
an
indirect holder, an investor’s rights relating to a global security will be
governed by the account rules of the investor’s financial institution and
of the depositary, as well as general laws relating to securities
transfers. We do not recognize an indirect holder as a holder of
securities and instead deal only with the depositary that holds the global
security.
If
securities are issued only in the form of a global security, an investor should
be aware of the following:
|
• |
an
investor cannot cause the securities to be registered in his or her
name,
and cannot obtain non-global certificates for his or her interest
in the
securities, except in the special situations we describe
below;
|
|
• |
an
investor will be an indirect holder and must look to his or her own
bank
or broker for payments on the securities and protection of his or
her
legal rights relating to the securities, as we describe under “Legal
Ownership of Securities”;
|
|
• |
an
investor may not be able to sell interests in the securities to some
insurance companies and to other institutions that are required by
law to
own their securities in non-book-entry
form;
|
|
• |
an
investor may not be able to pledge his or her interest in a global
security in circumstances where certificates representing the securities
must be delivered to the lender or other beneficiary of the pledge
in
order for the pledge to be
effective;
|
|
• |
the
depositary’s policies, which may change from time to time, will govern
payments, transfers, exchanges and other matters relating to an investor’s
interest in a global security. We and any applicable trustee have no
responsibility for any aspect of the depositary’s actions or for its
records of ownership interests in a global security. We and the
trustee also do not supervise the depositary in any
way;
|
|
• |
the
depositary may, and we understand that DTC will, require that those who
purchase and sell interests in a global security within its book-entry
system use immediately available funds, and your broker or bank may
require you to do so as well; and
|
|
• |
financial
institutions that participate in the depositary’s book-entry system, and
through which an investor holds its interest in a global security,
may
also have their own policies affecting payments, notices and other
matters
relating to the securities. There may be more than one financial
intermediary in the chain of ownership for an investor. We do not
monitor and are not responsible for the actions of any of those
intermediaries.
|
Special
Situations When a Global Security will be Terminated
In
a few
special situations described below, the global security will terminate and
interests in it will be exchanged for physical certificates representing those
interests. After that exchange, the choice of whether to hold securities
directly or in street name will be up to the investor. Investors must
consult their own banks or brokers to find out how to have their interests
in
securities transferred to their own name, so that they will be direct
holders. We have described the rights of holders and street name investors
above.
The
global security will terminate when the following special situations
occur:
|
• |
if
the depositary notifies us that it is unwilling, unable or no longer
qualified to continue as depositary for that global security and
we do not
appoint another institution to act as depositary within 90
days;
|
|
• |
if
we notify any applicable trustee that we wish to terminate that global
security; or
|
|
• |
if
an event of default has occurred with regard to securities represented
by
that global security and has not been cured or
waived.
|
The
prospectus or prospectus supplement may also list additional situations for
terminating a global security that would apply only to the particular series
of
securities covered by the prospectus or prospectus supplement. When a
global security terminates, the depositary, and not we or any applicable
trustee, is responsible for deciding the names of the institutions that will
be
the initial direct holders.
We
may
sell the securities through underwriters or dealers, through agents, or directly
to one or more purchasers. The accompanying prospectus
or prospectus supplement will describe the terms of the offering of the
securities, including:
|
· |
the
name or names of any underwriters;
|
|
· |
the
purchase price of the securities being offered and the proceeds we
will
receive from the sale;
|
|
· |
any
over-allotment options pursuant to which underwriters may purchase
additional securities from us;
|
|
· |
any
agency fees or underwriting discounts and other items constituting
agents’
or underwriters’ compensation; and
|
|
· |
any
discounts or concessions allowed or reallowed or paid to
dealers.
|
If
underwriters are used in the sale, they will acquire the securities for their
own account and may resell the securities from time to time in one or more
transactions at a fixed public offering price or at varying prices determined
at
the time of the sale. The obligations of the underwriters to purchase the
securities will be subject to the conditions set forth in the applicable
underwriting agreement. We may offer the securities to the public through
underwriting syndicates represented by managing underwriters or by underwriters
without a syndicate. Subject to certain conditions, the underwriters will
be obligated to purchase all the securities offered by the prospectus
or prospectus
supplement. We may change from time to time the public offering price and
any discounts or concessions allowed or reallowed or paid to dealers. We
may use underwriters with whom we have a material relationship. We will
describe such relationships in the prospectus supplement naming the underwriter
and the nature of any such relationship.
We
may
sell securities directly or through agents we designate from time to time.
We
will name any agent involved in the offering and sale of the securities, and
we
will describe any commissions we will pay the agent in the prospectus
supplement. Unless the prospectus
or prospectus
supplement states otherwise, our agent will act on a best efforts basis for
the
period of its appointment.
We
may
provide agents and underwriters with indemnification against civil liabilities
related to this offering, including liabilities under the Securities Act, or
contribution with respect to payments that the agents or underwriters may make
with respect to these liabilities. Agents and underwriters may engage in
transactions with, or perform services for, us in the ordinary course of
business.
Rules of
the Securities and Exchange Commission may limit the ability of any underwriters
to bid for or purchase securities before the distribution of the securities
is
completed. However, underwriters may engage in the following activities in
accordance with the rules:
Stabilizing
transactions. Underwriters
may make bids or purchases for the purpose of pegging, fixing or maintaining
the
price of the shares, so long as stabilizing bids do not exceed a specified
maximum.
Over-allotments
and syndicate covering transactions. Underwriters
may sell more shares of our common stock than the number of shares that they
have committed to purchase in any underwritten offering. This over-allotment
creates a short position for the underwriters. This short position may involve
either “covered” short sales or “naked” short sales. Covered short sales are
short sales made in an amount not greater than the underwriters’ over-allotment
option to purchase additional shares in any underwritten offering. The
underwriters may close out any covered short position either by exercising
their
over-allotment option or by purchasing shares in the open market. To determine
how they will close the covered short position, the underwriters will consider,
among other things, the price of shares available for purchase in the open
market, as compared to the price at which they may purchase shares through
the
over-allotment option. Naked short sales are short sales in excess of the
over-allotment option. The underwriters must close out any naked position by
purchasing shares in the open market. A naked short position is more likely
to
be created if the underwriters are concerned that, in the open
market
after pricing, there may be downward pressure on the price of the shares that
could adversely affect investors who purchase shares in the
offering.
Penalty
bids. If
underwriters purchase shares in the open market in a stabilizing transaction
or
syndicate covering transaction, they may reclaim a selling concession from
other
underwriters and selling group members who sold those shares as part of the
offering.
Similar
to other purchase transactions, an underwriter’s purchases to cover the
syndicate short sales or to stabilize the market price of our securities may
have the effect of raising or maintaining the market price of our securities
or
preventing or mitigating a decline in the market price of our securities.
As a result, the price of the securities may be higher than the price that
might otherwise exist in the open market. The imposition of a penalty bid
might also have an effect on the price of shares if it discourages resales
of
the securities.
If
commenced, the underwriters may discontinue any of the activities at any
time.
Any
underwriters who are qualified market makers on the Nasdaq National Market
may
engage in passive market making transactions in the securities on the Nasdaq
National Market in accordance with Rule 103 of Regulation M, during the
business day prior to the pricing of the offering, before the commencement
of
offers or sales of the securities. Passive market makers must comply with
applicable volume and price limitations and must be identified as passive market
makers. In general, a passive market maker must display its bid at a price
not
in excess of the highest independent bid for such security; if all independent
bids are lowered below the passive market maker’s bid, however, the passive
market maker’s bid must then be lowered when certain purchase limits are
exceeded.
In
compliance with guidelines of the National Association of Securities Dealers,
or
NASD, the maximum consideration or discount to be received by any NASD member
or
independent broker dealer may not exceed 8% of the aggregate amount of the
securities offered pursuant to this prospectus and any applicable prospectus
supplement.
The
validity of the securities offered hereby has been passed upon for us by
Kilpatrick Stockton LLP, Atlanta, Georgia.
BDO
Seidman LLP,
independent
public accountants,
has
audited the
financial statements of Interface, Inc. included
in our Annual Report on Form 10-K for the year ended January
1, 2006,
and
management’s assessment of the effectiveness of our internal control over
financial reporting as of January
1, 2006,
as set
forth in their reports, which are incorporated by reference in this prospectus
and elsewhere in the registration statement. Our financial statements and
schedule and management’s assessment are incorporated by reference in reliance
on BDO
Seidman LLP’s
reports, given on their authority as experts in accounting and
auditing.
PART
II
INFORMATION
NOT REQUIRED IN PROSPECTUS
ITEM
14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION
The
following table sets forth the expenses in connection with the registration
of
securities being registered hereby. All of the amounts shown are estimated,
except the SEC registration fee, and relate to this Form S-3 only.
SEC
Registration Fee
|
|
$
|
(1)
|
National
Association of Securities Dealers Inc. Registration Fee
|
|
|
(2)
|
Printing
and Engraving Expenses
|
|
|
(2)
|
Legal
Fees and Expenses
|
|
|
(2)
|
Accounting
Fees and Expenses
|
|
|
(2)
|
Miscellaneous
|
|
|
(2)
|
Total
|
|
|
(2)
|
_____________________________
(1) Deferred
in reliance on Rule 456(b).
(2) The
amount of these expenses is not presently known.
ITEM
15. INDEMNIFICATION OF DIRECTORS AND OFFICERS
As
provided under Georgia law, the Registrant’s Articles of Incorporation, as
amended, provide that a director shall not be personally liable to the
Registrant or its shareholders for monetary damages for breach of duty of care
or any other duty owed to Registrant as a director, except that such provision
shall not eliminate or limit the liability of a director (1) for any
appropriation, in violation of his duties, of any business opportunity or the
Registrant, (2) for acts or omissions which involve intentional misconduct
or a
knowing violation of law, (3) for unlawful corporate distributions, or (4)
for
any transaction from which the director received an improper
benefit.
Under
Article VII of the Registrant’s Bylaws, as amended, the Registrant is authorized
to indemnify its officers and directors for any liability and expense incurred
by them in connection with or resulting from any threatened, pending or
completed legal action or other proceeding or investigation by reason of his
being or having been an officer or director. An officer or director may only
be
indemnified if he acted in good faith and in a manner he reasonably believed
to
be in, or not opposed to, the best interests of the Registrant, and, with
respect to a criminal matter, he did not have reasonable cause to believe that
his conduct was unlawful. No officer or director who has been adjudged liable
for the improper receipt of a personal benefit is entitled to
indemnification.
Any
officer or director who has been wholly successful on the merits or otherwise
in
an action or proceeding in his official capacity is entitled to indemnification
as to expenses by the Registrant. All other determinations in respect of
indemnification shall be made by either: (1) a majority vote of a quorum of
disinterested directors; (2) independent legal counsel selected in accordance
with the Bylaws and at the request of the Board; or (3) the holders of a
majority of the Registrant’s stock who at such time are entitled to vote for the
election of directors.
The
provisions of the Registrant’s Bylaws on indemnification are consistent in all
material respects with the laws of the State of Georgia, which authorize
indemnification of corporate officers and directors.
Subject
to the foregoing, the Registrant has entered into indemnification agreements
with each of its executive officers and directors providing such officers and
directors indemnification and expense advancement to the fullest extent
permitted by applicable law and the Registrant’s Articles of Incorporation and
Bylaws, subject to certain limitations and procedural requirements. The
Registrant’s directors and executive officers are also insured against losses
arising from any claim against them as such for wrongful acts or omissions,
subject to certain limitations.
ITEM
16. EXHIBITS.
Exhibit
Number
|
|
Description
of Exhibit
|
1.1
|
—
|
Form
of underwriting agreement or placement agreement will be filed
as an
exhibit to a Current Report on Form 8-K and incorporated herein by
reference.
|
3.1
|
—
|
Restated
Articles of Incorporation (included as Exhibit 3.1 to the Company’s
quarterly report on Form 10-Q for the quarter ended July 5, 1998
(the
“1998 Second Quarter 10-Q”), previously filed with the Commission and
incorporated herein by reference).
|
3.2
|
—
|
Bylaws,
as amended and restated (included as Exhibit 3.2 to the Company’s
quarterly report on Form 10-Q for the quarter ended April 1, 2001,
previously filed with the Commission and incorporated herein by
reference).
|
4.1
|
—
|
See
Exhibits 3.1 and 3.2 for provisions in the Company’s Articles of
Incorporation and Bylaws defining the rights of holders of Common
Stock of
the Company.
|
4.2
|
—
|
Rights
Agreement between the Company and Wachovia Bank, N.A., dated as
of March
4, 1998, with an effective date of March 16, 1998 (included as
Exhibit
10.1A to the Company’s registration statement on Form 8-A/A dated March
12, 1998, previously filed with the Commission and incorporated
herein by
reference).
|
4.3
|
—
|
Form
of Indenture governing the Company’s 7.3% Senior Notes due 2008, among the
Company, Certain U.S. subsidiaries of the Company, as Guarantors,
and
First Union National Bank, as Trustee (the “1998 Indenture”) (included as
Exhibit 4.1 to the Company’s registration statement on Form S-3/A, File
No. 333-46611, previously filed with the Commission and incorporated
herein by reference); Supplement No. 1 to the 1998 Indenture, dated
as of
December 31, 2002 (included as Exhibit 4.4 to the Company’s annual report
on Form 10-K for the year ended December 29, 2002 (the “2002 10-K”),
previously filed with the Commission and incorporated herein by
reference); Supplement No. 2 to the 1998 Indenture, dated as of
June 18, 2003 (included as Exhibit 4.2 to the Company’s quarterly
report on Form 10-Q for the quarter ended June 29, 2003 (the “2003 Second
Quarter 10-Q”), previously filed with the Commission and incorporated
herein by reference); and Supplement No. 3 to the 1998 Indenture,
dated as
of January 10, 2005 (included as Exhibit 99.1 to the Company’s current
report on Form 8-K dated February 15, 2005, previously filed with
the
Commission and incorporated herein by reference).
|
4.4
|
—
|
Indenture
governing the Company’s 10.375% Senior Notes due 2010, among the Company,
certain U.S. subsidiaries of the Company, as Guarantors, and First
Union
National Bank, as Trustee (the “2002 Indenture”) (included as Exhibit 4.5
to the Company’s annual report on Form 10-K for the year ended December
30, 2001 (the “2001 10-K”), previously filed with the Commission and
incorporated herein by reference); Supplemental Indenture related
to the
2002 Indenture, dated as of December 31, 2002 (included as Exhibit
4.5 to
the 2002 10-K, previously filed with the Commission and incorporated
herein by reference); Second Supplemental Indenture related to
the 2002
Indenture, dated as of June 18, 2003 (included as Exhibit 4.3 to
the 2003
Second Quarter 10-Q, previously filed with the Commission and incorporated
herein by reference); and Third Supplemental Indenture related
to the 2002
Indenture, dated as of January 10, 2005 (included as Exhibit 99.2
to the
Company’s current report on Form 8-K dated February 15, 2005, previously
filed with the Commission and incorporated herein by
reference).
|
4.5
|
—
|
Indenture
governing the Company’s 9.5% Senior Subordinated Notes due 2014, dated as
of February 4, 2004, among the Company, certain U.S. subsidiaries
of the
Company, as guarantors, and SunTrust Bank, as Trustee (the “2004
Indenture”) (included as Exhibit 4.6 to the Company’s annual report on
Form 10-K for the year ended December 28, 2003 (the “2003 10-K”),
previously filed with the Commission and incorporated herein by
reference); and First Supplemental Indenture related to the 2004
Indenture, dated as of January 10, 2005 (included as Exhibit 99.3
to the
Company’s current report on Form 8-K dated February 15, 2005, previously
filed with the Commission and incorporated herein by
reference).
|
4.8
|
—
|
Form
of any senior note with respect to each particular series of senior
debt
securities issued hereunder will be filed as an exhibit to a Current
Report on Form 8-K and incorporated herein by
reference.
|
4.9
|
—
|
Form
of any subordinated note with respect to each particular series
of
subordinated debt securities issued hereunder will be filed as
an exhibit
to a Current Report of Form 8-K and incorporated herein by
reference.
|
4.10
|
—
|
Form
of warrant agreement will be filed as exhibits to a Current Report
on
Form 8-K and incorporated herein by
reference.
|
4.11
|
—
|
Form
of certificate of designation with respect to any preferred stock
certificate and related form of preferred stock certificate will
be filed
as an exhibit to a Current Report on Form 8-K and incorporated herein
by reference.
|
5.1
|
—
|
Legal
Opinion of Kilpatrick Stockton LLP
|
8.1
|
—
|
Opinion
of tax counsel on certain U.S. federal income tax matters will
be filed as
exhibits to a current report on Form 8-K and incorporated herein by
reference.
|
12.1
|
—
|
Computation
of Ratio of Earnings to Fixed Charges will be filed as an exhibit
to a
Current Report on Form 8-K and incorporated herein by
reference.
|
23.1
|
—
|
Consent
of Kilpatrick Stockton, LLP (see Exhibit 5).
|
23.2
|
—
|
Consent
of BDO Seidman, LLP.
|
24.1
|
—
|
Power
of Attorney (see signature page of this Registration
Statement).
|
|
—
|
|
ITEM
17. UNDERTAKINGS.
(a) The
undersigned Registrant hereby undertakes:
(1) To
file,
during any period in which offers or sales are being made, a post-effective
amendment to this Registration Statement:
(i) To
include any prospectus required by Section 10(a)(3) of the Securities
Act.
(ii) To
reflect in the prospectus any facts or events arising after the effective date
of the Registration Statement (or the most recent post-effective amendment
thereof) which, individually or in the aggregate, represent a fundamental change
in the information set forth in the Registration Statement. Notwithstanding
the
foregoing, any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that which was
registered) and any deviation from the low or high end of the estimated maximum
offering range may be reflected in the form of prospectus filed with the
Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than a 20 percent change in the maximum aggregate
offering price set forth in the “Calculation of Registration Fee” table in the
effective Registration Statement.
(iii) To
include any material information with respect to the plan of distribution not
previously disclosed in the Registration Statement or any material change to
such information in the Registration Statement.
provided,
however,
that:
(B) Paragraphs
(a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply if the
Registration Statement is on Form S-3 or Form F-3, and the information required
to be included in a post-effective amendment by those paragraphs is contained
in
periodic reports filed with or furnished to the Commission by the Registrant
pursuant to Section 13 or 15(d) of the Exchange Act that are incorporated by
reference in this Registration Statement, or is contained in a form of
prospectus filed pursuant to Rule 424(b) that is part of this Registration
Statement.
(2) That,
for
the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona
fide
offering
thereof.
(3) To
remove
from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the
offering.
(5) That,
for
purpose of determining any liability under the Securities Act to any
purchaser:
(i) If
the
registrant is relying on Rule 430B (§230.430B of this chapter):
(A) Each
prospectus filed by the registrant pursuant to Rule 424(b)(3) (§230.424(b)(3) of
this chapter) shall be deemed to be part of the registration statement as of
the
date the filed prospectus was deemed part of and included in the registration
statement; and
(B) Each
prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7)
(§230.424(b)(2), (b)(5), or (b)(7) of this chapter) as part of a registration
statement in reliance on Rule 430B relating to an offering made pursuant to
Rule
415(a)(1)(i), (vii), or (x) (§230.415(a)(1)(i), (vii), or (x) of this chapter)
for the purpose of providing the information required by section 10(a) of the
Securities Act of 1933 shall be deemed to be part of and included in the
registration statement as of the earlier of the date such form of prospectus
is
first used after effectiveness or the date of the first contract of sale of
securities in the offering described in the prospectus. As provided in Rule
430B, for liability purposes of the issuer and any person that is at that date
an underwriter, such date shall be deemed to be a new effective date of the
registration statement relating to the securities in the registration statement
to which that prospectus relates, and the offering of such securities at that
time shall be deemed to be the initial bona
fide
offering
thereof. Provided,
however,
that no
statement made in a registration statement or prospectus that is part of the
registration statement or made in a document incorporated or deemed incorporated
by reference into the registration statement or prospectus that is part of
the
registration statement will, as to a purchaser with a time of contract of sale
prior to such effective date, supersede or modify any statement that was made
in
the registration statement or prospectus that was part of the registration
statement or made in any such document immediately prior to such effective
date;
or
(ii) If
the
registrant is subject to Rule 430C (§230.430C of this chapter), each prospectus
filed pursuant to Rule 424(b) as part of a registration statement relating
to an
offering, other than registration statements relying on Rule 430B or other
than
prospectuses filed in reliance on Rule 430A (§230.430A of this chapter), shall
be deemed to be part of and included in the registration statement as of the
date it is first used after effectiveness. Provided,
however,
that no
statement made in a registration statement or prospectus that is part of the
registration statement or made in a document incorporated or deemed incorporated
by reference into the registration statement or prospectus that is part of
the
registration statement will, as to a purchaser with a time of contract of sale
prior to such first use, supersede or modify any statement that was made in
the
registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such date of first
use.
(6) That,
for
purpose of determining any liability under the Securities Act to any purchaser
in the initial distribution of the securities, the undersigned registrant
undertakes that in a primary offering of securities of the undersigned
registrant pursuant to this registration statement, regardless of the
underwriting method used to sell the securities to the purchaser, if the
securities are offered or sold to such purchaser by means of any of the
following communications, the undersigned registrant will be a seller to the
purchaser and will be considered to offer or sell such securities to such
purchaser.
(i) Any
preliminary prospectus or prospectus of the undersigned registrant relating
to
the offering required to be filed pursuant to Rule 424 (§230.424 of this
chapter);
(ii) Any
free
writing prospectus relating to the offering prepared by or on behalf of the
undersigned registrant or used or referred to by the undersigned
registrant;
(iii) The
portion of any other free writing prospectus relating to the offering containing
material information about the undersigned registrant or its securities provided
by or on behalf of the undersigned registrant; and
(iv) Any
other
communication that is an offer in the offering made by the undersigned
registrant to the purchaser.
(b) The
undersigned Registrant hereby undertakes that, for purposes of determining
any
liability under the Securities Act, each filing of the Registrant’s annual
report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and,
where applicable, each filing of an employee benefit plan’s annual report
pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference
in the Registration Statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona
fide
offering
thereof.
(e) The
undersigned registrant hereby undertakes to deliver or cause to be delivered
with the prospectus, to each person to whom the prospectus is sent or given,
the
latest annual report, to security holders that is incorporated by reference
in
the prospectus and furnished pursuant to and meeting the requirements of Rule
14a-3 or Rule 14c-3 under the Securities Exchange Act of 1934; and, where
interim financial information required to be presented by Article 3 of
Regulation SX is not set forth in the prospectus, to deliver or caused to be
delivered to each person to whom the prospectus is sent or given, the latest
quarterly report that is specifically incorporated by reference in the
prospectus to provide such interim financial information.
(h) Insofar
as indemnification for liabilities arising under the Securities Act may be
permitted to directors, officers and controlling persons of the Registrant
pursuant to the foregoing provisions, or otherwise, the Registrant has been
advised that in the opinion of the Commission such indemnification is against
public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Registrant of expenses incurred
or
paid by a director, officer or controlling person of the Registrant in the
successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
SIGNATURES
Pursuant
to the requirements of the Securities Act, the Registrant certifies that it
has
reasonable grounds to believe that it meets all of the requirements for filing
on Form S-3 and has duly caused this Registration Statement to be signed on
its
behalf by the undersigned, thereunto duly authorized, in the City of Atlanta,
State of Georgia, on May 16, 2006.
|
INTERFACE,
INC.
|
|
|
|
By:
/s/
Daniel T. Hendrix
|
|
Daniel
T. Hendrix,
|
|
President
and Chief Executive Officer
|
KNOW
ALL
MEN BY THESE PRESENTS, that each person whose signature appears below
constitutes and appoints Daniel T. Hendrix and Patrick C. Lynch as
attorneys-in-fact, having the power of substitution, for them in any and all
capacities, to sign any amendments to this Registration Statement on Form S-3
and to file the same, with exhibits thereto, and other documents in connection
therewith, with the Commission, hereby ratifying and confirming all that said
attorneys-in-fact, or their substitute or substitutes, may do or cause to be
done by virtue hereof.
Pursuant
to the requirements of the Securities Act, this Registration Statement has
been
signed by the following persons in the capacities indicated on the
16th
day of
May, 2006.
Signature
|
Title
|
|
|
/s/
Ray
C. Anderson
|
|
Ray
C. Anderson
|
Non-Executive
Chairman of the Board of Directors
|
|
|
|
|
/s/
Daniel T. Hendrix
|
|
Daniel
T. Hendrix
|
President,
Chief Executive
|
|
Officer
and Director
|
|
(Principal
Executive Officer)
|
|
|
|
|
/s/
Patrick C. Lynch
|
|
Patrick
C. Lynch
|
Vice
President and Chief Financial Officer
(Principal
Financial and Principal
Accounting
Officer)
|
|
|
/s/
Edward C. Callaway
|
|
Edward
C. Callaway
|
Director
|
|
|
|
|
/s/
Dianne
Dillon-Ridgley
|
|
Dianne
Dillon-Ridgley
|
Director
|
|
|
|
|
/s/
Carl I. Gable
|
|
Carl
I. Gable
|
Director
|
|
|
|
|
/s/
June M. Henton
|
|
June
M. Henton
|
Director
|
/s/
Christopher G. Kennedy
|
|
Christopher
G. Kennedy
|
Director
|
|
|
|
|
/s/
J. Smith Lanier, II
|
|
J.
Smith Lanier, II
|
Director
|
|
|
|
|
/s/
James B. Miller, Jr.
|
|
James
B. Miller, Jr.
|
Director
|
|
|
|
|
/s/
Thomas R. Oliver
|
|
Thomas
R. Oliver
|
Director
|
|
|
|
|
/s/
Clarinus C. Th. van Andel
|
|
Clarinus
C. Th. van Andel
|
Director
|
|
|
Exhibit
Number
|
Description of
Exhibit
|
5.1
|
Legal
Opinion of Kilpatrick Stockton LLP
|
23.1
|
Consent
of Kilpatrick Stockton, LLP (see Exhibit 5).
|
23.2
|
Consent
of BDO Seidman, LLP.
|
24.1
|
Power
of Attorney (see signature page of this Registration
Statement).
|
II-8